Grown Rogue International (GRUSF) Depreciation and Depletion (2009 - 2015)
Grown Rogue International's (GRUSF) quarterly Depreciation and Depletion came in at $445.0 in Q3 2015, up 44.64% year-on-year from $307.65 in Q3 2014, and up 19.2% quarter-over-quarter from $373.34 in Q2 2015.
Grown Rogue International (GRUSF) Depreciation and Depletion (2009 - 2015) Analysis & Trends
Grown Rogue International's Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $445.0 for Q3 2015.
- On a quarterly basis, Depreciation and Depletion rose 44.64% year-over-year to $445.0 in Q3 2015; TTM through Aug 2015 was $1338.1, a 53.09% decrease from a year earlier, with the FY2015 full-year figure at $1243.2, down 45.34% from the prior year.
- Depreciation and Depletion grew to $445.0 in Q3 2015 per GRUSF's latest filing, from $373.34 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $5324.7 in Q3 2012 and bottomed at $212.14 in Q4 2014.
- The 4-year median for Depreciation and Depletion is $1291.9 (2014), against an average of $2128.5.
- Across the five-year window, Depreciation and Depletion plunged 89.06% in 2014 and soared 44.64% in 2015, its largest moves.
- Year by year, Depreciation and Depletion stood at $4204.8 in 2012, then slumped by 80.52% to $819.04 in 2013, then tumbled by 74.1% to $212.14 in 2014, then jumped by 109.77% to $445.0 in 2015.
- Per Business Quant, the three latest GRUSF Depreciation and Depletion figures stand at $445.0 (Q3 2015), $373.34 (Q2 2015), and $212.14 (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2015 | 445.00 |
| Aug 31, 2015 | 445.00 |
| May 31, 2015 | 373.34 |
| May 31, 2015 | 373.34 |
| Nov 30, 2014 | 212.14 |
| Nov 30, 2014 | 212.14 |
| Aug 31, 2014 | 307.65 |
| Aug 31, 2014 | 307.65 |
| May 31, 2014 | 433.67 |
| May 31, 2014 | 433.67 |
| Feb 28, 2014 | 1,291.91 |
| Feb 28, 2014 | 1,291.91 |
| Nov 30, 2013 | 819.04 |
| Nov 30, 2013 | 819.04 |
| Aug 31, 2013 | 2,812.51 |
| Aug 31, 2013 | 2,812.51 |
| May 31, 2013 | 1,946.41 |
| May 31, 2013 | 1,946.41 |
| Feb 28, 2013 | 4,243.78 |
| Feb 28, 2013 | 4,243.78 |